Infant Formula Made in America Act of 2024

The Infant Formula Made in America Act of 2024, also known as Bill 118 s 4005, is a piece of legislation currently being considered by the US Congress. The purpose of this bill is to promote the production and sale of infant formula that is made in the United States.

If passed, this bill would require that all infant formula sold in the US be manufactured in the country. This is intended to ensure that the formula meets strict safety and quality standards, as well as to support American businesses and create jobs in the infant formula industry.

Proponents of the bill argue that domestic production of infant formula will help to reduce the risk of contamination and ensure that babies are receiving safe and nutritious products. They also believe that this legislation will help to boost the US economy and support American workers. Opponents of the bill, however, argue that it could lead to higher prices for infant formula, as domestic production may be more expensive than importing formula from other countries. They also raise concerns about potential shortages of formula if domestic manufacturers are unable to meet demand. Overall, the Infant Formula Made in America Act of 2024 is a controversial piece of legislation that has sparked debate among lawmakers and stakeholders. Its ultimate impact on the infant formula industry and consumers remains to be seen.